Portland cement for bone tissue engineering: Effects of processing and metakaolin blends

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 98 B, Issue 2, 2011, Pages 308-315

  Gallego Perez, Daniel ^a   Higuita Castro, Natalia ^a,b   Quiroz, Felipe García ^b   Posada, Olga M ^b   Lõpez, Luis E ^b   Litsky, Alan S ^a   Hansford, Derek J ^a  

^a Ohio State University   (United States)

^b UNIVERSIDAD CES   (Colombia)

Author keywords

bone defect; carbonation; load bearing; metakaolin; Portland cement

Indexed keywords

ALKALINE PHOSPHATASE ACTIVITY; BONE DEFECT; BONE TISSUE ENGINEERING; CELL RESPONSE; COMPRESSIVE TESTS; CYTOCOMPATIBILITY; CYTOTOXIC; DIRECT CONTACT; HUMAN OSTEOBLAST-LIKE CELLS; LOAD BEARING; METAKAOLINS; PRE-TREATMENT; SAMPLE MORPHOLOGY; SCAFFOLDING MATERIALS; SIMULATED BODY FLUIDS;

ALKALINITY; BEARINGS (STRUCTURAL); BIOMECHANICS; BONE; CARBON DIOXIDE; ENERGY DISPERSIVE SPECTROSCOPY; MECHANICAL PROPERTIES; PHOSPHATASES; PORTLAND CEMENT; SCANNING ELECTRON MICROSCOPY; TISSUE; TISSUE ENGINEERING;

BONE CEMENT;

ALKALINE PHOSPHATASE; CARBON DIOXIDE; CEMENT; KAOLIN;

ARTICLE; ATMOSPHERE; BODY FLUID; BONE TISSUE; CELL STRUCTURE; CYTOTOXICITY; ELECTRON MICROSCOPY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; OSTEOBLAST; SCANNING ELECTRON MICROSCOPY; TISSUE ENGINEERING;

BONE AND BONES; BONE CEMENTS; CONSTRUCTION MATERIALS; HUMANS; KAOLIN; MATERIALS TESTING; OSTEOBLASTS; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 79960082355     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.31853     Document Type: Article

References (37)

1. Brooks PM,. The burden of musculoskeletal disease-a global perspective. Clin Rheumatol 2006; 25: 778-781. (Pubitemid 44473138)
2. Takagi S, Chow LC, Hirayama S, Eichmiller FC,. Properties of elastomeric calcium phosphate cement-chitosan composites. Dent Mater 2003; 19: 797-804.
3. Xu HHK, Weir MD, Simon CG,. Injectable and strong nano-apatite scaffolds for cell/growth factor delivery and bone regeneration. Dent Mater 2008; 24: 1212-1222.
4. Ministry AS, Mikos AG,. Tissue engineering strategies for bone regeneration. Adv Biochem Eng Biotechnol 2005; 94: 1-22. (Pubitemid 44608653)
5. Salgado AJ, Coutinho OP, Reis RL,. Bone tissue engineering: State of the art and future trends. Macromol Biosci 2004; 4: 743-765. (Pubitemid 39257140)
6. Hutmacher DW,. Scaffold design and fabrication technologies for engineering tissues-state of the art and future perspectives. J Biomater Sci Polym Ed 2001; 12: 107-124. (Pubitemid 32335467)
7. Zhang H, Hutmacher DW, Chollet F, Poo AN, Burdet E,. Microrobotics and MEMS-based fabrication techniques for scaffold-based tissue engineering. Macromol Biosci 2005; 5: 477-489. (Pubitemid 40933985)
8. Kokubo T, Kim HM, Kawashita M,. Novel bioactive materials with different mechanical properties. Biomaterials 2003; 24: 2161-2175. (Pubitemid 36434034)
9. Friedman CD, Costantino PD, Takagi S, Chow LC,. Bone source⢠hydroxyapatite cement: A novel biomaterial for craniofacial skeletal tissue engineering and reconstruction. J Biomed Mater Res (Appl Biomater) 1998; 43: 428-432. (Pubitemid 28544102)
10. Adams CS, Mansfield K, Perlot RL, Shapiro IM,. Matrix regulation of skeletal cell apoptosis. J Biol Chem 2001; 276: 20316-20322.
11. Brown GD, Mealey BL, Nummikoski PV, Bifano SL, Waldrop TC,. Hydroxyapatite cement implant for regeneration of periodontal osseous defects in humans. J Periodontol 1998; 69: 146-157. (Pubitemid 128518343)
12. Kim HM, Kishimoto K, Miyaji F, Kokubo T, Yao T, Suetsugu Y, Tanaka J, Nakamura T,. Composition and structure of the apatite formed on PET substrates in SBF modified with various ionic activity products. J Biomed Mater Res 1999; 46: 228-235.
13. Rezwan K, Chen QZ, Blaker JJ, Boccaccini AR,. Biodegradable and bioactive polymer/inorganic composite scaffolds for bone tissue engineering. Biomaterials 2006; 27: 3413-3431.
14. Sarkar NK, Caicedo R, Ritwik P, Moiseyeva R, Kawashima I,. Physicochemical basis of the biological properties of mineral trioxide aggregate. J Endod 2005; 31: 97-100. (Pubitemid 40222786)
15. Roberts HW, Toth JM, Berzins DW, Charlton DG,. Mineral trioxide aggregate material use in endodontic treatment: A review of the literature. Dent Mater 2008; 24: 149-164. (Pubitemid 350299065)
16. Camilleri J, Montesin FE, Curtis RV, Ford TRP,. Characterization of Portland cement for use as a dental restorative material. Dent Mater 2006; 22: 569-575.
17. Camilleri J, Montesin FE, Brady K, Sweeney R, Curtis RV, Ford TRP,. The constitution of mineral trioxide aggregate. Dent Mater 2005; 21: 297-303. (Pubitemid 40583937)
18. Dammaschke T, Gerth HUV, Züchner H, Schäfer E,. Chemical and physical surface and bulk material characterization of white ProRoot MTA and two Portland cements. Dent Mater 2005; 21: 731-738. (Pubitemid 41000232)
19. Tay FR, Pashley DH,. Guided tissue remineralization of partially demineralized human dentine. Biomaterials 2007; 29: 1127-1137.
20. AÃtcin PC,. Cements of yesterday and today Concrete of tomorrow. Cem Concr Res 2000; 30: 1349-1359.
21. Sabir BB, Wild S, Bai J,. Metakaolin and calcined clays as pozzolans for concrete: A review. Cem Concr Compos 2001; 23: 441-454. (Pubitemid 32798113)
22. Rowles M, O'Connor B,. Chemical optimisation of the compressive strength of aluminosilicate geopolymers synthesised by sodium silicate activation of metakaolinit. J Mater Chem 2003; 13: 1161-1165.
23. Kokubo T, Takadama H,. How useful is SBF in predicting in vivo bone bioactivity? Biomaterials 2006; 27: 2907-2815.
24. Vallet-Regi M, Arcos D,. Silicon substituted hydroxyapatites. A method to upgrade calcium phosphate based implants. J Mater Chem 2005; 15: 1509-1516. (Pubitemid 40625957)
25. Northup SJ, Cammack JN,. Mammalian cell culture models. In:, Von Recum AF, editor. Handbook of Biomaterials Evaluation: Scientific, Technical, and Clinical Testing of Implant Materials. Philadelphia: Taylor & Francis; 1999. pp 328-329.
26. Uliasz TF, Hewett SJ,. A microtiter trypan blue absorbance assay for the quantitative determination of excitotoxic neuronal injury in cell culture. J Neurosci Methods 2000; 100: 157-163.
27. Ali NN, Rowe J, Teich NM,. Constitutive expression of non-bone/liver/kidney alkaline phosphatase in human osteosarcoma cell lines. J Bone Miner Res 1996; 11: 512-520. (Pubitemid 26109071)
28. 2 dopants. J Am Ceram Soc 2006; 89: 2675-2688. (Pubitemid 44266407)
29. Cultrone G, Sebastian E, Ortega Huertas M,. Forced and natural carbonation of lime-based mortars with and without additives: Mineralogical and textural changes. Cem Concr Res 2005; 35: 2278-2289. (Pubitemid 41690200)
30. Glasser FP,. Fundamental aspects of cement solidification and stabilization. J Hazard Mater 1997; 52: 151-170.
31. Andrade AL, Ferreira JMF, Domingues RZ,. Surface modifications of alumina-silica glass fiber. J Biomed Mater Res B Appl Biomater 2004; 70: 378-383. (Pubitemid 39006918)
32. Gallego D, Higuita N, Garcia F, Ferrell N, Hansford DJ,. Bioactive coatings on Portland cement substrates: Surface precipitation of apatite-like crystals. Mater Sci Eng C Biomim Mater Sens Syst 2008; 28: 347-352. (Pubitemid 351308070)
33. Huang FM, Tai KW, Chou MY, Chang YC,. Cytotoxicity of resin-, zinc oxide-eugenol-, and calcium hydroxide-based root canal sealers on human periodontal ligament cells and permanent V79 cells. Int Endod J 2002; 35: 153-158.
34. Ozawa S, Kasugai S,. Evaluation of implant materials (hydroxyapatite, glass-ceramics, titanium) in rat bone marrow stromal cell culture. Biomaterials 1996; 17: 23-29. (Pubitemid 126755188)
35. 2 bone scaffold coated with hydroxyapatite with fluorapatite intermediate layer. Biomaterials 2003; 24: 3277-3284. (Pubitemid 36577676)
36. Popat KC, Leoni L, Grimes CA, Desai TA,. Influence of engineered titania nanotubular surfaces on bone cells. Biomaterials 2007; 28: 3188-3197. (Pubitemid 46654214)
37. Puertas F, Palacios M, Vazquez T,. Carbonation process of alkali-activated slag mortars. J Mater Sci 2006; 41: 3071-3082. (Pubitemid 43821140)